AU
UK
CA
NZ
IND
US
Last update at 2026-06-23T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
DuPont Upgrades WAVE PRO Capabilities With RO and NI Tech
Thu 05 Mar 26, 03:12 PMBASFY's Shanghai Plant Begins Production of Elastollan FR TPU
Thu 05 Mar 26, 03:10 PMAlbemarle Wraps Up Controlling Stake Sale in Ketjen to KPS
Wed 04 Mar 26, 02:19 PMShould You Investigate Balchem Corporation (NASDAQ:BCPC) At US$165?
Mon 12 May 25, 01:19 PMBalchem First Quarter 2025 Earnings: Beats Expectations
Mon 28 Apr 25, 01:05 PMBalchem Corporation Reports First Quarter 2025 Financial Results
Thu 24 Apr 25, 11:00 AMBalchem Corporation Releases 2024 Sustainability Report
Tue 22 Apr 25, 11:00 AMBalchem (NASDAQ:BCPC) Ticks All The Boxes When It Comes To Earnings Growth
Thu 20 Mar 25, 01:14 PMBalchem Full Year 2024 Earnings: In Line With Expectations
Sat 22 Feb 25, 12:14 PM| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 199.03M | 166.45M | 137.26M | 133.75M | 125.23M |
| Minority interest | - | - | - | - | - |
| Net income | 154.84M | 128.47M | 108.54M | 105.37M | 96.10M |
| Selling general administrative | 67.42M | 67.59M | 55.73M | 55.66M | 41.73M |
| Selling and marketing expenses | 75.37M | 68.92M | 74.40M | 67.41M | 60.41M |
| Gross profit | 370.63M | 336.21M | 302.06M | 280.45M | 243.17M |
| Reconciled depreciation | 45.69M | 47.97M | 54.94M | 51.85M | 48.88M |
| Ebit | 209.25M | 182.98M | 159.87M | 145.19M | 127.50M |
| Ebitda | 254.44M | 230.95M | 214.81M | 197.03M | 176.38M |
| Depreciation and amortization | 45.19M | 47.97M | 54.94M | 51.85M | 48.88M |
| Non operating income net other | - | - | - | -1.16900M | 0.19M |
| Operating income | 218.33M | 182.91M | 159.19M | 145.19M | 127.50M |
| Other operating expenses | 818.83M | 770.77M | 763.25M | 797.17M | 671.52M |
| Interest expense | 10.22M | 16.53M | 22.61M | 10.27M | 2.46M |
| Tax provision | 44.19M | 37.98M | 28.72M | 28.38M | 29.13M |
| Interest income | - | - | - | - | - |
| Net interest income | -10.21900M | -16.52800M | -22.61300M | -10.26800M | -2.45600M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 44.19M | 37.98M | 28.72M | 28.38M | 29.13M |
| Total revenue | 1037.16M | 953.68M | 922.44M | 942.36M | 799.02M |
| Total operating expenses | 152.30M | 153.30M | 142.86M | 135.26M | 115.67M |
| Cost of revenue | 666.53M | 617.48M | 620.38M | 661.91M | 555.85M |
| Total other income expense net | -19.30200M | -16.45600M | -21.93200M | -11.43700M | -2.26900M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 154.84M | 128.47M | 108.54M | 105.37M | 96.10M |
| Net income applicable to common shares | - | - | - | 105.37M | 96.10M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 1707.56M | 1575.37M | 1625.14M | 1624.51M | 1199.33M |
| Intangible assets | 163.29M | 165.05M | 191.21M | 213.29M | 94.67M |
| Earning assets | - | - | - | - | - |
| Other current assets | 16.00M | 13.79M | 14.99M | 18.00M | 10.53M |
| Total liab | 450.15M | 425.46M | 571.16M | 686.23M | 322.31M |
| Total stockholder equity | 1257.41M | 1149.91M | 1053.98M | 938.28M | 877.01M |
| Deferred long term liab | - | - | - | 62.78M | 46.45M |
| Other current liab | 108.23M | 95.15M | 58.08M | 78.70M | 85.20M |
| Common stock | 2.14M | 2.17M | 2.15M | 2.15M | 2.15M |
| Capital stock | 2.14M | 2.17M | 2.15M | 2.15M | 2.15M |
| Retained earnings | 1121.40M | 997.49M | 897.49M | 814.49M | 732.14M |
| Other liab | - | - | - | 89.60M | 69.94M |
| Good will | 816.38M | 780.03M | 778.91M | 769.51M | 523.95M |
| Other assets | - | - | - | 10.82M | 11.67M |
| Cash | 74.57M | 49.52M | 64.45M | 66.56M | 103.24M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 176.38M | 157.69M | 148.49M | 140.04M | 143.80M |
| Current deferred revenue | - | -3.32800M | 30.68M | - | - |
| Net debt | 117.44M | 158.53M | 265.89M | 374.01M | 5.33M |
| Short term debt | 3.82M | 3.33M | 4.22M | 4.02M | 2.36M |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 192.01M | 208.04M | 330.33M | 440.57M | 108.57M |
| Other stockholder equity | 92.33M | 174.00M | 145.65M | 128.81M | 147.72M |
| Property plant equipment | - | - | - | 271.36M | 246.81M |
| Total current assets | 365.61M | 313.77M | 314.24M | 335.80M | 322.23M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | - | 168.78M | 258.40M |
| Short term investments | - | - | - | - | - |
| Net receivables | 143.60M | 119.66M | 125.28M | 131.58M | 117.41M |
| Long term debt | 164.00M | 190.00M | 309.57M | 440.57M | 108.57M |
| Inventory | 131.45M | 130.80M | 109.52M | 119.67M | 91.06M |
| Accounts payable | 60.42M | 54.74M | 55.50M | 57.32M | 56.24M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 41.55M | -23.74700M | 8.69M | -7.15400M | -4.99300M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | 2.15M | 2.15M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | 814.49M | 732.14M |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 14.42M | 13.46M | 12.87M | -47.66600M | 11.67M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 1341.94M | 1261.60M | 1310.90M | 1288.71M | 877.09M |
| Capital lease obligations | 16.69M | 18.04M | 20.77M | 20.04M | 9.47M |
| Long term debt total | - | - | - | - | 122.28M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 0.00000M | -59.73600M | -37.43700M | -0.15000M | -35.30000M |
| Change to liabilities | - | - | - | -15.24700M | 51.85M |
| Total cashflows from investing activities | -43.89100M | -59.73600M | - | -416.01400M | -35.30000M |
| Net borrowings | -26.19400M | -119.78500M | - | 299.78M | -55.15900M |
| Total cash from financing activities | -152.81000M | -133.81500M | -153.32100M | 246.68M | -102.17800M |
| Change to operating activities | - | - | - | 1.45M | 10.93M |
| Net income | 154.84M | 128.47M | 108.54M | 105.37M | 96.10M |
| Change in cash | 25.05M | -14.93200M | -2.11300M | -36.67900M | 18.67M |
| Begin period cash flow | 49.52M | 64.45M | 66.56M | 103.24M | 84.57M |
| End period cash flow | 74.57M | 49.52M | 64.45M | 66.56M | 103.24M |
| Total cash from operating activities | 216.56M | 182.00M | 183.76M | 138.54M | 160.51M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 45.69M | 47.97M | 54.94M | 51.85M | 48.88M |
| Other cashflows from investing activities | -43.56800M | 0.09M | - | -415.86400M | 2.15M |
| Dividends paid | 28.29M | 25.58M | 22.87M | 20.71M | 18.72M |
| Change to inventory | 3.63M | -22.79100M | 10.53M | -7.80400M | -21.02300M |
| Change to account receivables | -20.85300M | 5.58M | 6.97M | -3.61800M | -20.70000M |
| Sale purchase of stock | -107.63600M | -5.68200M | -4.46900M | -35.42300M | -35.23900M |
| Other cashflows from financing activities | -16.88700M | 17.23M | 5.24M | 436.98M | 11.94M |
| Change to netincome | - | - | - | 5.21M | 4.60M |
| Capital expenditures | 43.49M | 35.66M | 37.89M | 50.29M | 37.45M |
| Change receivables | - | - | - | -3.61800M | -20.70000M |
| Cash flows other operating | - | - | - | 2.78M | -1.26500M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | -30.79900M | 23.04M |
| Change in working capital | -7.46300M | -6.11700M | 20.01M | -25.22200M | 10.93M |
| Stock based compensation | 18.06M | 16.68M | 16.05M | 13.22M | 10.80M |
| Other non cash items | -0.83500M | 1.77M | -4.96500M | 1.68M | -0.25700M |
| Free cash flow | 173.07M | 146.34M | 145.87M | 88.25M | 123.06M |
Sector: Basic Materials Industry: Specialty Chemicals
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BCPC Balchem Corporation |
0.47 0.28% | 166.04 | 37.29 | 33.22 | 5.54 | 4.52 | 5.58 | 22.72 |
| LIN Linde plc Ordinary Shares |
-4.45 0.86% | 512.26 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
0.17 0.45% | 37.98 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
0.02 0.01% | 189.41 | 30.66 | 24.51 | 4.69 | 4.05 | 4.36 | 15.61 |
| SHW Sherwin-Williams Co |
6.00 1.89% | 322.90 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
5 Paragon Drive, Montvale, NJ, United States, 07645
| Name | Title | Year Born |
|---|---|---|
| Mr. Theodore L. Harris | Chairman, CEO & Pres | 1965 |
| Mr. Carl Martin Bengtsson | CFO & Treasurer | 1977 |
| Mr. William A. Backus CPA, CPA | Chief Accounting Officer | 1966 |
| Mr. Mark A. Stach | Exec. Officer | 1962 |
| Mr. Martin Luther Reid | Chief Supply Chain Officer | 1967 |
| Ms. Hatsuki Miyata | Gen. Counsel & Corp. Sec. | NA |
| Mr. Jonathan Griffin | Sr. VP and GM of Animal Nutrition & Health | NA |
| Mr. Frederic Boned | Sr. VP and GM of Human Nutrition & Health | 1978 |
| Mr. Theodore L. Harris | Chairman, CEO & President | 1965 |
| Mr. Carl Martin Bengtsson | Executive VP, CFO, Treasurer & GM of Animal Nutrition and Health | 1978 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...